Mobile Menu - OpenMobile Menu - Closed

Welch Applauds Vermont’s Groundbreaking Prescription Drug Pricing Transparency Law

June 3, 2016
Press Release
First of its kind state legislation will require drug makers to justify price increases to consumers

WASHINGTON – Rep. Peter Welch (D-VT), a co-chair of the House Democratic Caucus Prescription Drug Task Force, issued the following statement in support of S.216, Vermont’s new law that will require drug makers to justify prescription drug price increases to consumers. Governor Peter Shumlin signed the first-of-its-kind legislation Thursday.  
“Once again Vermont is leading the nation,” Rep. Peter Welch said. “Thanks to Governor Shumlin and the Vermont General Assembly for making Vermont the first state to shine a light on exorbitant prescription drug pricing. The market for prescription drugs is fundamentally broken. This new law will be a boost to my efforts in Congress to bring transparency to the pharmaceutical industry and make prescription drugs more affordable for consumers across the country.”

In January, Rep. Welch testified before the Vermont Senate Health and Welfare and the House Human Services and Health Care committees on drug pricing transparency.